Automatic Measurement of Wet AMD's Imaging Biomarkers
About the Research Project
Program
Award Type
Standard
Award Amount
$100,000
Active Dates
April 01, 2010 - March 31, 2013
Grant ID
M2010008
Co-Principal Investigator(s)
Glenn Jaffe, MD, Duke University
Summary
We are developing a fully-automated software program with demonstrated high accuracy that is able to detect, segment, and analyze neovascular AMD (NVAMD) pathology seen on spectral domain optical coherence tomography (SDOCT) and compare these data to corresponding features on other imaging modalities.
We anticipate that the software tools developed in this proposal will be readily adopted by clinicians, clinical study sites, and image Reading Centers to better identify NVAMD at the earliest stages, to quantify disease progression, and to measure response to therapy.
Progress Updates
So far, we have achieved significant progress on all aims of this project, often exceeding our proposed project timeline. Moreover, our experience in this project helped us to achieve exciting progress in related dry-AMD projects. We have submitted two articles on automatic segmentation of normal and AMD eyes to the most prestigious journals of our field (one already published and one under review). Moreover, one of our abstracts received the National Eye Institute’s travel award at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, May 2011. The automated segmentation technology that we have developed for AMD eyes, has also resulted in a serendipitous discovery of a novel technique for automatic segmentation of corneal images, resulting in yet another submission of a journal article.
Overall, in part based on our work in this project, we have submitted 5 journal papers. Based on the year one results, we are confident to attain all our major goals based on the proposed timeline. We anticipate that the software tools developed in this proposal will be readily adopted by clinicians, clinical study sites, and image Reading Centers to better identify NVAMD at the earliest stages, to quantify disease progression, and to measure response to therapy.
Related Grants
Macular Degeneration Research
Simultaneous Structural and Functional Imaging of the Retinal Pigment Epithelium
Active Dates
July 01, 2014 - March 01, 2017

Principal Investigator
Omid Masihzadeh, PhD
Current Organization
University of Colorado School of Medicine
Macular Degeneration Research
Improved Characterization of Early AMD Phenotype by Combining Novel Imaging, Physiological Markers, and Genotypes
Active Dates
July 01, 2013 - June 30, 2015

Principal Investigator
Chi Luu, PhD
Current Organization
Centre for Eye Research Australia (Australia)
Macular Degeneration Research
Quantitative Evaluation of Environmental Risk for AMD
Active Dates
July 01, 2012 - June 30, 2016

Principal Investigator
Milam A. Brantley, Jr., MD, PhD
Current Organization
Vanderbilt University Medical Center